Essex Investment Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 420 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 428 |
|
|
2022
Q4 | – | Sell |
-1,053
| Closed | -$256K | – | 437 |
|
|
2022
Q3 | $256K | Buy |
1,053
+404
| +62% | +$98.2K | 0.04% | 266 |
|
|
2022
Q2 | $297K | Hold |
649
| – | – | 0.05% | 266 |
|
|
2022
Q1 | $573K | Buy |
649
+16
| +3% | +$14.1K | 0.07% | 258 |
|
|
2021
Q4 | $617K | Buy |
633
+313
| +98% | +$305K | 0.07% | 259 |
|
|
2021
Q3 | $511K | Buy |
+320
| New | +$511K | 0.06% | 270 |
|
|
2015
Q2 | – | Sell |
-2
| Closed | -$42K | – | 342 |
|
|
2015
Q1 | $42K | Hold |
2
| – | – | 0.01% | 307 |
|
|
2014
Q4 | $63K | Hold |
2
| – | – | 0.01% | 317 |
|
|
2014
Q3 | $66K | Buy |
+2
| New | +$66K | 0.01% | 342 |
|